M&A Deal Summary |
|
|---|---|
| Date | 2015-04-01 |
| Target | IRIX Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Patheon BV |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1974 |
| Sector | Life Science |
| Employees | 5,900 |
| Revenue | 1.9B USD (2016) |
Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science M&A | 4 of 4 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: South Carolina M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2015 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-03-20 |
Agere Pharmaceuticals
Bend,, Oregon, United States Agere Pharmaceuticals, Inc., a privately-held CDMO, that specializes in improving the absorption rate of medications (bioavailability). |
Buy | - |
